Meredith Ian T. - 28 Dec 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP Global Chief Med Officer
Signature
/s/ Vance R. Brown, Attorney-in-fact
Issuer symbol
BSX
Transactions as of
28 Dec 2021
Net transactions value
-$303,248
Form type
4
Filing time
29 Dec 2021, 15:33:15 UTC
Next filing
03 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale $303,248 -7,018 -21% $43.21 26,243 28 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.